COVID-19: Gastrointestinal Manifestations and Complications

Abstract

The virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The common symptoms of COVID-19 infection are fever and respiratory symptoms, but it can also involve the gastrointestinal tract (GIT), resulting in manifestations such as diarrhea, nausea and/or vomiting and abdominal pain. The emergence of COVID-19 led to public health emphasis on droplet transmission and precautions of contact with respiratory secretions. However, mounting evidence demonstrates detection of SARS-CoV-2 RNA in stool samples of COVID-19 patients. It has also been demonstrated that the host receptor angiotensin-converting-enzyme-2 (ACE-2) is highly expressed not just in respiratory cells but also in gastrointestinal sites involving the glandular cells of gastric, duodenal, and rectal epithelium. This suggests that SARS-CoV-2 can infect the digestive system, serving as another route of transmission. This review aims to study the prevalence of some of the gastrointestinal manifestations following COVID-19 infection and findings of positive SARS-CoV-2 RNA in stool specimens while making parallels to the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) infection. We will also discuss the possible pathophysiology of COVID-19 related gastrointestinal involvement.

South Africa’s Battle Against COVID-19 Pandemic

“…When diagnosed with COVID-19, the individual could present asymptomatic or present symptoms similar to the flu. For instance, the individual may experience mild to severe symptoms such as fever, cough, difficulty breathing, fatigue, myalgia, sore throat, and loss of taste or smell [4,5] . Since the emergence of the coronavirus, countries across the globe have put in vigorous efforts to overcome the pandemic.…”

A Variant of Concern (VOC) Omicron: Characteristics, Transmissibility, and Impact on Vaccine Effectiveness

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a severe pneumonia outbreak in China in late December 2019 [1] . Then in early March 2020, it was declared a global pandemic known as COVID-19 [2,3] . Since the emergence of SARS-CoV-2 from Wuhan, Hubei province of China, in December 2019 [2,4] , this viral strain has spread like wildfire across the globe.…”

“…Then in early March 2020, it was declared a global pandemic known as COVID-19 [2,3] . Since the emergence of SARS-CoV-2 from Wuhan, Hubei province of China, in December 2019 [2,4] , this viral strain has spread like wildfire across the globe. It has undergone multiple mutations resulting in the emergence of variants of concern (VOCs), which are variants with evolutionary advantages [5] .…”

Cost-effectiveness of Public Health Strategies on COVID-19 Control: A Systematic Review

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which was first reported in Wuhan, China in December 2019 [1] , and declared a global pandemic on March 11, 2020 [2] has spread to every corner of the world and become one of the greatest public health challenges globally with over 503,000,000 confirmed cases and 6,218,000 deaths worldwide as of April 15 h , 2022 [3] . Recent evidence has shown exhibition of neurological, gastrointestinal, and long-term complications among post COVID-19 survivors [4][5][6] . The possible mechanism of which is the use of the angiotensin-converting enzyme 2 (ACE-2) receptors which are expressed in the central nervous system and various organs for SARS-COV-2 entry to the host cell [5] , and the inflammatory responses caused by the virus [6] .…”